Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuumfrom prevention, screening, diagnosis, and prognosis to disease and treatment monitoringto serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.

Fabricantes de medicamentos

Mr. David Ian Bell

Chief Corporation Devel., Legal & Data Protection Officer

Ms. Montserrat Gaja Llamas

Chief HR Officer

Mrs. Eva  Bastida Tubau

Corporation Vice President and Director of Scientific & Medical Affairs

Mr. Steven Francis Mayer J.D.

Executive Chairman

Mr. Raimon  Grifols Roura

Co-Chief Executive Officer & Executive Director

Mr. Mateo Florencio Borrás  Humbert

Corporation Vice President & Chief HR Officer

Mr. Alfredo Arroyo Guerra

Chief Financial Officer & Vice President

Ms. Nuria Pascual Lapeña

Vice President of Corporation Treasury, Risk Management Investor Relation & Sustainability Officer

Nombre	Capitalización
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.	0M
PT Kalbe Farma Tbk.	0M
Orion Oyj	0M
Abbott India Limited	0M
Johnson & Johnson	0M
Gland Pharma Limited	0M
Dimed S.A. Distribuidora de Medicamentos	0M
Grifols, S.A.	0M
Yifan Pharmaceutical Co., Ltd.	0M
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.	0M

Grifols, S.A.

Grifols, S.A. Lista de competidores

Principales competidores